Ellen M. Basu

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 14 papers. Top paper: “Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers”.

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

Cell(2020)10.1016/j.cell.2020.07.009

N/A

1.1DataRank · unranked

1205 citations

Han Sang Kim, Linda Bojmar, Kofi Ennu Gyan, Michele Cioffi, Jonathan M. Hernandez +95 more

Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma

Journal of Neuro-Oncology(2023)10.1007/s11060-022-04235-w

N/A

0.503DataRank · unranked

15 citations

Suzanne L. Wolden, Matthias Karajannis, Sofia Haque, Luca Pasquini, Onur Yildirim +10 more

A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete Remission

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3427

N/A

0.317DataRank · unranked

7 citations

Shakeel Modak, Audrey Mauguen, Ellen M. Basu, Kim Kramer, Stephen S. Roberts +3 more

Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease

EJNMMI Research(2024)10.1186/s13550-024-01127-0

N/A

0.176DataRank · unranked

2 citations

Brian Serencsits, Bae P. Chu, Lawrence T. Dauer, Maria Donzelli, Ellen M. Basu +3 more

Stage 4N neuroblastoma before and during the era of anti‐GD2 immunotherapy

International Journal of Cancer(2023)10.1002/ijc.34693

N/A

0DataRank · unranked

2 citations

Michael P. LaQuaglia, Fiorella Iglesias Cardenas, Ellen M. Basu, Justin T. Gerstle, Kim Kramer +5 more

18F-MFBG PET imaging in patients with neuroblastoma: Lesion targeting and comparison with MIBG.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10046

N/A

0DataRank · unranked

2 citations

Audrey Mauguen, Ellen M. Basu, Anita P. Price, Gerald Behr, Ryan Min +4 more

Long Prime–Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine

Vaccines(2024)10.3390/vaccines12060587

N/A

0DataRank · unranked

2 citations

Audrey Mauguen, Shakeel Modak, Ellen M. Basu, Yi Feng, Brian H. Kushner +2 more

Ovarian function in female survivors of high‐risk neuroblastoma

Pediatric Blood & Cancer(2024)10.1002/pbc.31181

N/A

0DataRank · unranked

3 citations

Amelia DeRosa, Caroline E. Kostrzewa, Chaya S. Moskowitz, Kimberly A. Bogardus, Zoltan Antal +10 more

Evolutionary Strategies AI Addresses Multiple Technical Challenges in Deep Learning Deployment: Proof-of-Principle Demonstration for Neuroblastoma Brain Metastasis Detection

Journal of Imaging Informatics in Medicine(2024)10.1007/s10278-024-01165-z

N/A

0DataRank · unranked

4 citations

Hrithwik Shalu, David A. Gutman, Andrei I. Holodny, Shakeel Modak, Ellen M. Basu +5 more

Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease

Research Square(2024)10.21203/rs.3.rs-3969388/v1

N/A

0DataRank · unranked

0 citations

Brian Serencsits, Bae P. Chu, Lawrence T. Dauer, Maria Donzelli, Ellen M. Basu +3 more

Local Control With Reduced-Dose Radiation Therapy for High-Risk Neuroblastoma: Results From a Prospective Clinical Trial

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.09.068

N/A

0DataRank · unranked

0 citations

Dana L. Casey, Brian H. Kushner, Shakeel Modak, Zhigang Zhang, Michael P. LaQuaglia +6 more

Characterization of on-target adverse events caused by TRK inhibitor therapy

Annals of Oncology(2020)10.1016/j.annonc.2020.05.006

N/A

0DataRank · unranked

86 citations

James Flory, Andrew Lin, Michael Offin, Christina J. Falcon, Yonina R. Murciano‐Goroff +16 more

Treatment and revaccination of children with paraneoplastic opsoclonus‐myoclonus‐ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience

Pediatric Blood & Cancer(2020)10.1002/pbc.28319

N/A

0DataRank · unranked

8 citations

Cheryl Fischer, Yi‐Chih Lin, Ellen M. Basu, Brian H. Kushner, Kevin C. De Braganca +2 more

Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease

Frontiers in Oncology(2023)10.3389/fonc.2022.1106597

N/A

0DataRank · unranked

3 citations

Brian H. Kushner, Angela Di Giannatale, Gunes Gundem, Shanita Li, Stephen S. Roberts +5 more